Home > Insider Trading > Filing (0001305773-17-000027)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1305773	Conformis Inc	CFMS	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1645522	Philipp Lang	C/O Conformis, Inc. 28 Crosby Drive Bedford MA 01730		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-01-25	43,534	$5.26	558,153	No	4	M	Direct
Common Stock	Acquisiton	2017-01-25	65,451	$5.50	623,604	No	4	M	Direct
Common Stock	Disposition	2017-01-25	108,985	$8.60	514,619	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2017-01-25	43,534	$0.00	43,534	$5.26
Common Stock	Stock Option (right to buy)	Disposition	2017-01-25	65,451	$0.00	65,451	$5.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
143,921		2021-09-27	No	4	M	Direct
59,827		2022-03-27	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,498	Indirect	See footnote.
Common Stock	930,904	Indirect	See footnote.

Footnotes

This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $8.6000-$8.6050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The shares are held directly by the Reporting Person's children.
The shares are held directly by the NP Irrevocable Trust udt dated 12/28/12. The Reporting Person's immediate family members are beneficiaries of the NP Irrevocable Trust udt dated 12/28/12, and the Reporting Person disclaims beneficial ownership of all shares except to the extent of his pecuniary interest therein.
This option is fully vested.